Prevail’s Gene Therapy PR001 Granted US Patent for Neuronopathic Gaucher
News
The U.S. Patent and Trademark Office has issued a patent related to PR001, Prevail Therapeutics‘ investigational gene therapy for neuronopathic Gaucher disease. The composition of matter patent grants coverage until ... Read more